$ANIK Recent News Two names for a two-way stock market

New Post Public Reply Private Reply Replies (0) Message Board

May 20, 2014 at 10:21 AM

$ANIK Recent News

Two names for a two-way stock market 2:42 p.m. May 8, 2014 - The Trading Deck
Nasdaq treads water while a few names show their stuff 2:36 p.m. May 6, 2014 - The Trading Deck
Dow edges to less-charted technical territory 11:48 a.m. May 1, 2014 - Michael Ashbaugh
Dow edges to less-charted territory 11:27 a.m. May 1, 2014 - Michael Ashbaugh
S&P 500 extends the break to ‘clear skies’ territory 11:46 a.m. March 6, 2014 - Michael Ashbaugh
Stock futures edge higher ahead of home sales 9:11 a.m. Feb. 26, 2014 - William L. Watts
First Solar shares burned as earnings disappoint 7:05 p.m. Feb. 25, 2014 - Wallace Witkowski
Amgen boosts biotech sector to close up 6:23 p.m. March 11, 2011 - Wallace Witkowski
Human Genome rallies against biotech downturn 6:04 p.m. March 10, 2011 - Wallace Witkowski
Illumina dives, Anika rallies on earnings reports 11:53 a.m. Oct. 28, 2009 - Val Brickates Kennedy
Genzyme, Merck lead as drug stocks move higher 1:04 p.m. Aug. 21, 2009 - Val Brickates Kennedy
Thursday's biggest gaining and declining stocks 5:07 p.m. Aug. 20, 2009 - MarketWatch
Drug stocks gain; Anika zooms on drug approval 12:32 p.m. Aug. 20, 2009 - Val Brickates Kennedy
Wednesday's biggest stock gainers and decliners 5:27 p.m. July 25, 2007 - Gabriel Madway
Stocks in focus for Wednesday 7:37 p.m. July 24, 2007 - MarketWatch
Friday's biggest stock gainers and decliners 4:42 p.m. April 13, 2007 - Michael Baron
Stocks in focus Friday 7:14 p.m. April 12, 2007 - Katherine Hunt
Anika Therapeutics receives CE Mark approval for Elevess 5:30 p.m. April 12, 2007 - Katherine Hunt
Anika Therapeutics up 5.3% at $14.10 10:46 a.m. Dec. 21, 2006 - Tomi Kilgore
Anika Thera gets FDA approval for cosmetic tissue augment 9:52 a.m. Dec. 21, 2006 - Thomas Middleton

IBD 50 High-Growth Shares Remain In Correction 5:55 p.m. May 9, 2014 - Investors Business Daily
Focus On Anika Therapeutics 6:09 a.m. May 8, 2014 - Seeking Alpha
10-Q: ANIKA THERAPEUTICS, INC. 5:30 p.m. May 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
Insider Trading Alert - ANIK, TRLA And AMED Traded By Insiders 10:15 a.m. May 5, 2014 - TheStreet.com
Anika Therapeutics' CEO Discusses Q1 2014 Results - Earnings Call Transcript 4:04 p.m. April 30, 2014 - Seeking Alpha
Notable earnings after Tuesday’s close 5:35 p.m. April 28, 2014 - Seeking Alpha
Some IBD 50 Stocks May Be Forming Bases 5:42 p.m. April 25, 2014 - Investors Business Daily
Facebook, Arris, Grifols Initiate New Bases 5:35 p.m. April 11, 2014 - Investors Business Daily
Biotech IPOs Adamas, Cerulean Slump In Trading Debut 3:02 p.m. April 10, 2014 - Investors Business Daily
PolyOne, Anika, Methode Among The Leading Small Caps 7:02 a.m. April 10, 2014 - Investors Business Daily
Biotechs, Medicals Get Hurt Amid Price-Inquiry News 5:26 p.m. March 21, 2014 - Investors Business Daily
10-K: ANIKA THERAPEUTICS INC 5:29 p.m. March 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
Mutual Funds Loading Up On These 3 Top-Rated Stocks 7:02 a.m. March 7, 2014 - Investors Business Daily
Insider Trading Alert - SWK, ANIK And NYT Traded By Insiders 10:15 a.m. March 4, 2014 - TheStreet.com
Anika Therapeutics (ANIK) Showing Signs Of A Dead Cat Bounce Today 9:55 a.m. March 3, 2014 - TheStreet.com
Cramer's Mad Money - 10 Biggest Gains (2/27/14) 6:22 a.m. Feb. 28, 2014 - Seeking Alpha
Anika Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 1:43 p.m. Feb. 27, 2014 - Seeking Alpha
Anika Therapeutics (ANIK) In A Perilous Reversal 9:46 a.m. Feb. 27, 2014 - TheStreet.com
Mid-Day Market Update: First Solar Falls On Downbeat Results; Anika Therapeutics Shares Jump 11:52 a.m. Feb. 26, 2014 - benzinga.com
Anika Arthritis Drug Approval Sends Stock Soaring 10:47 a.m. Feb. 26, 2014 - Investors Business Daily

Biotech Companies Report Quarterly Financial Results - Analyst Notes on Intrexon, Acorda, Anika, Sangamo and Spectrum 9:30 a.m. May 14, 2014 - PR Newswire - PRF
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 6:32 p.m. May 7, 2014 - PR Newswire - PRF
Anika Therapeutics Reports First Quarter 2014 Financial Results 4:08 p.m. April 29, 2014 - BusinessWire - BZX
Anika Therapeutics Announces Date of First-Quarter 2014 Financial Results Conference Call 5:09 p.m. April 16, 2014 - BusinessWire - BZX
Anika Therapeutics Announces First U.S. Commercial Sale of Monovisc® 2:31 p.m. April 15, 2014 - BusinessWire - BZX
Anika Therapeutics Announces Dismissal of MONOVISC® U.S. Patent Infringement Lawsuit 8:55 a.m. March 13, 2014 - BusinessWire - BZX
Anika Therapeutics to Present at Canaccord Genuity Musculoskeletal Conference March 11 5:06 p.m. March 4, 2014 - BusinessWire - BZX
Translational Regenerative Medicine: Market Prospects 2014-2024 12:35 p.m. Feb. 27, 2014 - PR Newswire - PRF
Chesapeake Energy Falls after Missing Estimates; Anika Therapeutics Gets FDA Approval for Monovisc 2:16 a.m. Feb. 27, 2014 - ACCESSWIRE
Anika Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results 5:06 p.m. Feb. 26, 2014 - BusinessWire - BZX
FDA Approves MONOVISC®, A New Single Injection Treatment for Treatment of Pain Due to Osteoarthritis of the Knee 5:00 p.m. Feb. 25, 2014 - BusinessWire - BZX
Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2013 Financial Results Conference Call 5:06 p.m. Feb. 12, 2014 - BusinessWire - BZX
Translational Regenerative Medicine: Market Prospects 2014-2024 11:11 a.m. Feb. 12, 2014 - PR Newswire - PRF
Anika Therapeutics to Present at the Tenth Annual Noble Financial Equity Conference on January 20 5:40 p.m. Jan. 9, 2014 - BusinessWire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 9:00 a.m. Dec. 24, 2013 - PR Newswire
Biotech Firms Participate in Upcoming Conferences; Sees Steady Numbers around Thanksgiving - Research Report on BioMarin, Halozyme, PDL BioPharma, Anika Therapeutics, and Exelis 9:00 a.m. Dec. 3, 2013 - PR Newswire
FDA Approvals, Public Offerings and Stock Price Movements - Research Report on BioMarin, AEterna Zentaris, Charles River, Anika Therapeutics and Halozyme Therapeutics 9:00 a.m. Nov. 25, 2013 - PR Newswire
Allegion plc Set to Join the S&P 500; J.C. Penney to Join S&P MidCap 400; Aeropostle, Anika Therapeutics to Join S&P SmallCap 600 6:47 p.m. Nov. 22, 2013 - PR Newswire
Presentations, Executive Appointments, and Quarterly Financial Reports - Research Report on Jazz Pharmaceuticals, Insulet, The Cooper Companies, Anika Therapeutics, and Sangamo Biosciences 9:00 a.m. Nov. 6, 2013 - PR Newswire
Anika Therapeutics Reports 20% Total Revenue Growth and Record Third-Quarter Earnings 4:05 p.m. Oct. 30, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Miracle League Marks Two Decades with Big Fundraising Win

A Double Decade Celebration of Dream and Dedication The Miracle League of the Triangle sure knows how to throw a party—for them, it's not just a gala; it's a testament to two decades of turning dreams into reality. On October 13th, over 300 guests gathered at the Angus Barn Pavilion in Cary, NC, proving that passion for inclusive baseball is just as alive as it was 20...

Extra Mile Day: 18 Years of Honoring Unsung Heroes

Pedaling for Purpose: A Journey That Sparked a Movement What started as a lone journey across America's roads has turned into a celebrated movement to honor those who often go unnoticed. Back in 2009, Shawn Anderson embarked on an unusual journey. Armed only with a bicycle and determination, he pedaled from San Francisco to Boston—over 4,000 miles in just 90 days. It...

Fidelis Care Opens $120K Workforce Grants for Aid

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Nelson Peltz Doubles Down: Burgers or Pucks?

Mixing Hockey and Hamburgers: The Peltz Way You'd think a guy like Nelson Peltz wouldn't be juggling hockey sticks and hamburgers at the same time, but here we are. The man, a mogul of sorts with Trian Fund Management, is hopping onto a board seat with a New York hockey company and, oh, by the way, throwing a non-binding $7.35-a-share cash proposal to snatch up Wendy's, a...

Jamaica's Tourism Rebounds Post-Hurricane Challenges

Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...

Virginia Cancer Specialists: Leaders in Trusted Cancer Care

Decades of Trust in Cancer Care Virginia Cancer Specialists isn't just another name in the sea of healthcare providers. That pride they're feeling? Well, they've got every right to it. Just slapped their physicians' names all over the latest Washingtonian's Top Doctors list for 2026. And this isn’t some under-the-table handshake deal. No, this list is shaped by peer...

Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....

Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Infoya Surges with 665% Growth, Wins Fast 50 Spot

From Humble Beginnings to High Achiever Alright, let's touch base on Canada's tech landscape for a moment. Infoya's leap into Deloitte's 2026 Technology Fast 50 isn't just a pat on the back—it's a flashing neon sign of what raw ambition mixed with a pinch of AI can cook up for you. They've banked a whopping 665% revenue growth from 2022 to 2025. Not bad for a company...

Heritage Wines Meet Non-Alcoholic Trend: New Deal

Wine Industry Shifts Gears Well, here's a twist that might just shake up the wine racks. C. Mondavi & Family, from the historic Charles Krug estate, is aligning with Missing Thorn—a name gaining traction in the non-alcoholic wine scene. It’s a move that not only raises eyebrows but could also expand your wine-tasting options come your next sober night out. So what...